AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $914K and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $1K to $15K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$914K netNet selling
- CongressSTOCK Act, last 180 days
- +$1K to +$15K netNet buying
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 1 awardAwards on record
Market overview
Fundamentals Oct 5- Open
- $33.67
- 52-wk high
- $46.00
- High
- $34.06
- 52-wk low
- $22.24
- Low
- $33.20
- Prev close
- $33.30
- Mkt cap
- $1.90B
- Volume
- 1.55M
- Fwd P/E
- 2.5x
- Beta
- 0.60
- P/S
- 19.3x
- P/B
- 2.0x
- Profit margin
- +0.0%
- Op margin
- -247.1%
- ROE
- -34.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about AGIO filings
Are insiders buying or selling Agios Pharm (AGIO) stock?
Net selling: insiders sold $914K and bought $0 of AGIO stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. $914K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Gheuens, Sarah (Chief Medical Officer), who sold $914K. The latest filing was on Aug 6, 2026.
Which members of Congress have traded AGIO recently?
Rep. Gilbert Cisneros (D) bought $1K to $15K on Aug 20, 2026, disclosed 21 days later. In total, 1 member disclosed 1 AGIO trade with trade dates in the last 180 days, filed a median 21 days after trading.
How current is this AGIO smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- AQ
AQR
$24.2M
added
- SU
Susquehanna
$45.5M
bought
- JC
JPMorgan Chase
$9.3M
added
What insiders are doing
What Congress is doing
Buys (1)
How top traders are positioned
No tracked top-trader positions in AGIO right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 9.1% above what analysts expected.
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
-$1.86 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | -$1.69 / -$1.86Alpha Vantage | +9.14% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 29, 2026 | -$1.69 / -$1.79Alpha Vantage | +5.59% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 12, 2026 | -$1.85 / -$1.95Alpha Vantage | +5.13% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | -$1.78 / -$1.90Alpha Vantage | +6.32% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | -$1.93 / -$1.75Alpha Vantage | -10.29% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 1, 2025 | -$1.55 / -$1.76Alpha Vantage | +11.93% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 13, 2025 | -$1.74 / -$1.63Alpha Vantage | -6.75% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 31, 2024 | -$1.47 / $7.91Alpha Vantage | -118.58% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 29, 2026, in 24 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $12.9M | $20.0M | $20.7M | $44.7M |
| Cost of what it sold | $3.1M | $3.1M | $2.7M | $3.0M |
| Gross profit | $9.8M | $16.8M | $18.1M | $41.7M |
| What it spent | ||||
| Research and development | $85.4M | $86.8M | $79.8M | $100.8M |
| Sales and admin | $41.3M | $51.6M | $48.3M | $51.5M |
| Total operating expenses | $126.7M | $138.4M | $128.1M | $152.3M |
| What was left | ||||
| Operating profit | -$116.9M | -$121.6M | -$110.0M | -$110.6M |
| Profit before tax | -$103.4M | -$109.1M | -$99.1M | -$100.7M |
| Tax | — | -$1.0M | — | — |
| Net profit | -$103.4M | -$108.0M | -$99.1M | -$100.7M |
| EBITDA | -$102.1M | -$107.8M | -$97.7M | -$109.2M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Macro
11 macro signals shaping AGIO right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results